富時羅素季度評審 無A股被剔除
富時羅素公布全球股票指數系列季度評審結果,當中只納入國聯證券(601456.SH)一隻A股股票,沒有A股股票被剔除,將於12月21日開市生效。
港股、A股、美國存託股票(ADS)共計23隻股票被納入,包括理想汽車、思摩爾國際(06969.HK)、泰格醫藥(03347.HK)、海普瑞(09989.HK)、康方生物-B(09926.HK)、移卡(09923.HK)、祖龍娛樂(09990.HK)、永泰生物(06978.HK)、鳳祥股份(09977.HK)、金融街物業(01502.HK)、開拓藥業(09939.HK)、弘陽服務(01971.HK)、嘉興燃氣(09908.HK)、宏力醫療管理(09906.HK)、新娛科控股(06933.HK)、力天影業(09958.HK)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.